Stacking MOTS-C with any of these makes sense when a patient is dealing with both a metabolic goal (fat loss, energy) and a tissue or immune issue (gut healing, joint recovery, post-illness rebuilding)
The most important unknowns (cardiovascular safety, evidence on hard kidney outcomes, head-to-head tirals etc) all report between now and 2028
Our review was based on a systematic PubMed search of randomized controlled trials (RCTs), observational studies, systematic reviews/meta-analyses, literature reviews, and case reports, published up to 2022, evaluating the combined treatment with a GLP-1RA and a SGLT2i in T2DM or prediabetes
Initial Effects: What You May Notice Within the first week, Microdosing GLP-1 may start optimizing mitochondrial function, while reducing oxidative stress, potentially slowing a key hallmark of aging
Compounded semaglutide contains the identical active pharmaceutical ingredient (API)the semaglutide peptideas brand-name Wegovy and Ozempic
I hope that it actually affects public policy for equitable access